ReviewFrontiers in immunology2017

Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.

Kristina M Ilieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.